Source: http://www.google.fr/patents/US9610159
Timestamp: 2018-01-20 15:25:51
Document Index: 287858357

Matched Legal Cases: ['art.\n7', 'application No. 14', 'Application No. 61', 'Application No. 61', 'Application No. 201480037269', 'art, 1999']

Brevet US9610159 - Structural members for prosthetic mitral valves - Google Brevets
A self-expanding wire frame for a pre-configured compressible transcatheter prosthetic cardiovascular valve, a combined inner frame/outer frame support structure for a prosthetic valve, and methods for deploying such a valve for treatment of a patient in need thereof, are disclosed....http://www.google.fr/patents/US9610159?utm_source=gb-gplus-shareBrevet US9610159 - Structural members for prosthetic mitral valves
Numéro de publication US9610159 B2
Numéro de demande US 14/950,656
Autre référence de publication US20160074160, US20170196688
Numéro de publication 14950656, 950656, US 9610159 B2, US 9610159B2, US-B2-9610159, US9610159 B2, US9610159B2
Inventeurs Mark Christianson, Chad Perrin, Zachary Tegels, Craig Ekvall, Robert Vidlund
Cessionnaire d'origine Tendyne Holdings, Inc.
Citations de brevets (699), Citations hors brevets (53), Classifications (31), Événements juridiques (1)
US 9610159 B2
A self-expanding wire frame for a pre-configured compressible transcatheter prosthetic cardiovascular valve, a combined inner frame/outer frame support structure for a prosthetic valve, and methods for deploying such a valve for treatment of a patient in need thereof, are disclosed.
an outer frame formed of expanded shape memory alloy;
an inner frame formed of shape memory alloy and coupled to the outer frame; a prosthetic valve leaflet assembly disposed within a first portion of the inner frame; and
a tether, a second portion of the inner frame compressed about an end of the tether along a flow axis defined in part by the prosthetic valve leaflet assembly.
2. The apparatus of claim 1, further comprising a radiopaque indicator formed on the outer frame.
3. The apparatus of claim 1, wherein the inner frame is connected to the outer frame by mechanical fasteners.
4. The apparatus of claim 1, wherein the outer frame is formed separately from and then coupled to the inner frame.
5. The apparatus of claim 1, wherein the end of the tether is a first end, a second end of the tether extending away from the second portion of the inner frame.
6. The apparatus of claim 5, wherein the outer frame, the inner frame, and the prosthetic valve leaflet assembly are configured to be delivered to a native annulus of an atrioventricular valve of a heart, the tether having a length sufficient to extend from the second portion of the inner frame through an opening in a wall of a ventricle of the atrioventricular valve and out of the wall when the outer frame is disposed in the native annulus of the atrioventricular valve of the heart.
7. The apparatus of claim 1, wherein a distal end of the outer frame is disposed distal to a distal end of the inner frame.
8. The apparatus of claim 1, wherein the flow axis extends at least from a distal end of the outer frame to a proximal end of the outer frame, and through an opening defined by the prosthetic valve leaflet assembly.
This application is a continuation of International Application No. PCT/US2014/040188, filed May 30, 2014, which claims priority to and is a continuation-in-part of U.S. patent application No. 14/155,417, filed Jan. 15, 2014, which claims priority to and the benefit of U.S. Provisional Application No. 61/829,076, filed May 30, 2013. International Application No. PCT/US2014/040188 also claims priority to and the benefit of U.S. Provisional Application No. 61/829,076, filed May 30, 2013. Each of the foregoing disclosures is hereby incorporated by reference in its entirety.
An improved transcatheter prosthetic heart valve includes structural members, such as in the form of wire frames, which provide support for the valve and aid in reducing or preventing leakage.
Valvular heart disease and specifically aortic and mitral valve disease is a significant health issue in the US Annually approximately 90,000 valve replacements are conducted in the US. Traditional valve replacement surgery, the orthotopic replacement of a heart valve, is an “open heart” surgical procedure. Briefly, the procedure necessitates a surgical opening of the thorax, initiation of extra-corporeal circulation with a heart-lung machine, stopping and opening the heart, excision and replacement of the diseased valve, and re-starting of the heart. While valve replacement surgery typically carries a 1-4% mortality risk in otherwise healthy persons, a significantly higher morbidity is associated to the procedure, largely due to the necessity for extra-corporeal circulation. Further, open heart surgery is often poorly tolerated in elderly patients.
Various problems exist in this field, including problems of insufficient articulation and sealing of the valve within the native annulus, pulmonary edema due to poor atrial drainage, perivalvular leaking around the installed prosthetic valve, lack of a good fit for the prosthetic valve within the native mitral annulus, atrial tissue erosion, excess wear on the valve structures, interference with the aorta at the posterior side of the mitral annulus, and lack of customization, to name a few. Accordingly, there is still a need for an improved prosthetic mitral valve.
Apparatus, systems, and methods include a self-expanding wire frames for a prosthetic cardiovascular valve. The prosthetic cardiovascular valve includes a cylindrical framework defining a lumen. The cylindrical framework includes multiple generally diamond-shaped members. Each diamond-shaped member defines multiple lateral vertices and multiple longitudinal vertices. Each diamond-shaped member is coupled to one or more other diamond-shaped members. Each coupling can be at or about each of the lateral vertices of the diamond-shaped member.
FIG. 1 is an exploded view of a prosthetic cardiovascular valve according to an embodiment.
FIG. 2 is an oblique projection of a three-diamond self-expanding wire frame as a cylindrical frame defining a lumen according to an embodiment.
FIG. 3 is a perspective side view of a three-diamond self-expanding wire frame as a cylindrical frame defining a lumen according to another embodiment.
FIG. 4 is an opened and flattened view of a three-diamond cylindrical frame showing the detail of wire rods, multiple spanning rods, and vertices, according to another embodiment.
FIG. 5 is an opened and flattened view of an open-V cylindrical frame showing the detail of wire rods, and vertices, according to another embodiment.
FIG. 6 is an opened and flattened view of a three-diamond cylindrical frame showing the detail of wire rods, spanning rods, and vertices, according to another embodiment.
FIG. 7 is an oblique projection of a four-diamond self-expanding wire frame as a cylindrical frame defining a lumen, according to another embodiment.
FIG. 8 is an opened and flattened view of a four-diamond cylindrical frame showing the detail of wire rods, multiple spanning rods, and vertices, according to another embodiment.
FIG. 9 is an opened and flattened view of an open-V cylindrical frame showing the detail of wire rods, and vertices, according to another embodiment.
FIG. 10 is an opened and flattened view of a four-diamond cylindrical frame showing the detail of wire rods, spanning rods, and vertices, according to another embodiment.
FIG. 11 is an oblique projection view of a three-square cylindrical frame showing the detail of wire rods, multiple spanning rods, and vertices, according to another embodiment.
FIG. 12 is an opened and flattened view of the frame of FIG. 11.
FIG. 13 is an exploded view of a prosthetic cardiovascular valve according to another embodiment.
FIGS. 14A-14C show initial, partially expanded, and fully expanded states of an outer frame according to an embodiment.
FIG. 15 is an exploded view of a prosthetic cardiovascular valve according to another embodiment.
FIG. 16 is an opened and flattened view of an unexpanded inner wireframe structure, according to an embodiment.
FIGS. 17 and 18 are side and bottom views, respectively, of the inner wireframe structure of FIG. 16 in an expanded configuration.
FIG. 19 is an opened and flattened view of an unexpanded outer frame according to an embodiment.
FIGS. 20 and 21 are side and top views, respectively, of the outer frame of FIG. 19 in an expanded configuration.
FIGS. 22-24 are side, front, and top views of an assembly of the inner wireframe structure of FIGS. 16-18 and the outer frame of FIGS. 19-21, forming a support structure for a prosthetic valve, according to an embodiment.
FIG. 1 is an exploded view of one embodiment of a pre-configured compressible transcatheter prosthetic cardiovascular valve 10. In this embodiment, valve 10 includes an inner structure or assembly 12, and an outer structure or assembly 14. Valve 10 may be coupled to a tether 160, and a tether anchor 154.
Inner assembly 12 includes a self-expanding frame 100, an outer cylindrical wrap 152 disposed about the inner wire frame (to acts as a cover to prevent valvular leakage) and a leaflet structure 136 (comprised of articulating leaflets 138 that define a valve function). The leaflet structure 136 may be sewn to the inner wireframe 100. The wireframe 100 also has (tether) attachment apertures 111 to which the tether 160 can be attached. Tether 160 is connected to tether anchor 154, which in this embodiment is implemented as an epicardial securing pad.
Outer assembly 14 includes an outer stent or frame 144, an outer cover 150, and a cuff covering 148. In this embodiment, outer frame 144 has a flared, articulating collar or cuff 146 over which the cuff covering 148 is disposed. Cuff 146 has a D-shaped section 162 to accommodate and solve left ventricular outflow tract (LVOT) obstruction issues.
Cuff 146 may be configured a substantially flat plate that projects beyond the diameter of the tubular body of outer frame 144 to form a rim or border. The terms flared end, cuff, flange, collar, bonnet, apron, or skirting used interchangeable herein. When the tubular body of frame 144 is pulled through the aperture of a mitral valve aperture, the mitral annulus, such as by tether loops, in the direction of the left ventricle, the cuff acts as a collar to stop the frame from traveling any further through the mitral valve aperture. The entire prosthetic valve is held by longitudinal forces between the cuff, which is seated in the left atrium and mitral annulus, and the ventricular tethers attached to the left ventricle.
Cuff 146 may be formed from a stiff, flexible shape-memory material such as the nickel-titanium alloy material Nitinol® formed as wire, and covered by cuff covering 148, which may be formed of stabilized tissue or other suitable biocompatible or synthetic material. In one embodiment, the cuff is constructed from independent articulating radial tines or posts of wire extending axially around the circumference of the bend or seam where cuff 146 transitions to the tubular body of frame 144 (in an integral flared end or cuff) or where cuff 146 is attached to the frame body (in an implementation in which they are separate, but joined components).
With cuff cover 148 in place articulating radial tines or posts of wire provide the cuff the ability to move up and down, to articulate, along the longitudinal axis that runs through the center of frame 144. In other words, the individual articulating radial tines or posts of wire can independently move up and down, and can spring back to their original position due to the relative stiffness of the wire. The tissue or material that covers the cuff wire has a certain modulus of elasticity such that, when attached to the wire of the cuff, is able to allow the wire spindles to move. This flexibility gives the cuff, upon being deployed within a patient's heart, the ability to conform to the anatomical shape necessary for a particular application. In the example of a prosthetic mitral valve, the cuff is able to conform to the irregularities of the left atrium and shape of the mitral annulus, and to provide a tight seal against the atrial tissue adjacent the mitral annulus and the tissue within the mitral annulus. As stated previously, this feature provides a degree of flexibility in sizing the mitral valve and prevents blood from leaking around the implanted prosthetic heart valve.
An additional aspect of the cuff dimension and shape is that, when fully seated and secured, the edge of the cuff preferably should not be oriented laterally into the atrial wall, in which orientation it might produce a penetrating or cutting action on the atrial wall.
In some embodiments, the wire spindles of the cuff are substantially uniform in shape and size. In some embodiments, each loop or spindle may be of varying shapes and sizes. In this example, it is contemplated that the articulating radial tines or posts of wire may form a pattern of alternating large and small articulating radial tines or posts of wire, depending on where the valve is being deployed. In the case of a prosthetic mitral valve, pre-operative imaging may allow for customizing the structure of the cuff depending on a particular patient's anatomical geometry in the vicinity of the mitral annulus.
The cuff is constructed so as to provide sufficient structural integrity to withstand the intracardiac forces without collapsing.
Inner frame 100 and outer frame or frame 144, including cuff 146, are preferably formed to be deformed (compressed and/or expanded) and, when released, return to their original (undeformed) shapes. To achieve this, the components are preferably formed of materials, such as metals or plastics, that have shape memory properties. With regards to metals, Nitinol® has been found to be especially useful since it can be processed to be austenitic, martensitic or super elastic. Martensitic and super elastic alloys can be processed to demonstrate the required compression features. Thus, inner frame 100 and outer frame or frame 144, including cuff 145, are preferably constructed of Nitinol®, and are capable of maintaining their functions while under longitudinal forces that might cause a structural deformation or valve displacement. Other shape memory alloys, such as Cu—Zn—Al—Ni alloys, and Cu—Al—Ni alloys, may be used.
Inner frame 100 and outer frame or frame 144, including cuff 146, are preferably formed from a laser cut, thin-walled tube of Nitinol®, The laser cuts form regular cutouts in the thin Nitinol® tube. Secondarily the tube is placed on a mold of the desired shape, heated to the martensitic temperature and quenched. The treatment of the frame in this manner will form a flared end or cuff that has shape memory properties and will readily revert to the memory shape at the calibrated temperature.
Alternatively, these components may be constructed from braided wire
The cuff provides several functions. The first function is to inhibit perivalvular leakage and regurgitation of blood around the prosthesis. By flexing and sealing across the irregular contours of the annulus and atrium, leakage is minimized or prevented.
The second function of the cuff is to provide an adjustable and/or compliant bioprosthetic valve. The heart and its structures undergo complex conformational changes during the cardiac cycle. For example, the mitral valve annulus has a complex geometric shape known as a hyperbolic paraboloid that is shaped like a saddle, with the horn being anterior, the seat back being posterior, and the left and right valleys located medially and laterally. Beyond this complexity, the area of the mitral annulus changes over the course of the cardiac cycle. Further, the geometry of the tricuspid valve and tricuspid annulus continues to be a topic of research, posing its own particular problems. Accordingly, compliance is a very important but unfortunately often overlooked requirement of cardiac devices. Compliance here refers to the ability of the valve to change conformation with the native annulus in order to maintain structural position and integrity throughout the cardiac cycle. Compliance with the motion of the heart is a particularly useful feature, especially the ability to provide localized compliance where the underlying surfaces are acting differently from the adjacent surfaces. This ability to vary throughout the cardiac cycle allows the valve to remain seated and properly deployed in a manner not heretofore provided.
The third function of the cuff is to enable the valve, during implantation surgery, to conform to the irregular surfaces of the atrium. This function can be enhanced by the use of independent tethers, allowing for side-to-side fitting of the valve within the annulus. For example, where three tethers are used, they can be spaced circumferentially about 120 degrees relative to each other, which allows the surgeon to observe whether or where perivalvular leaking might be occurring and to pull on one side or the other to create localized pressure and reduce or eliminate the leakage.
The fourth function of the cuff is to counter the forces that act to displace the prosthesis toward/into the ventricle (i.e. atrial pressure and flow-generated shear stress) during ventricular filling.
The heart is known to generate an average left atrial pressure between about 8 and 30 mm Hg (about 0.15 to 0.6 psi). This left atrial filling pressure is the expected approximate pressure that would be exerted in the direction of the left ventricle when the prosthesis is open against the outer face of the flared end or cuff as an anchoring force holding the flared end or cuff against the atrial tissue that is adjacent the mitral valve. Cuff 146 counteracts this longitudinal pressure against the prosthesis in the direction of the left ventricle to keep the valve from being displaced or slipping into the ventricle. In contrast, left ventricular systolic pressure, normally about 120 mm Hg, exerts a force on the closed prosthesis in the direction of the left atrium. The tethers counteract this force and are used to maintain the valve position and withstand the ventricular force during ventricular contraction or systole. Accordingly, cuff 146 has sufficient structural integrity to provide the necessary tension against the tethers without being dislodged and pulled into the left ventricle. After a period of time, changes in the geometry of the heart and/or fibrous adhesion between prosthesis and surrounding cardiac tissues may assist or replace the function of the ventricular tethers in resisting longitudinal forces on the valve prosthesis during ventricular contraction.
Additional features of the cuff include that it functions to strengthen the leaflet assembly/frame complex by providing additional structure. Further, during deployment, the cuff functions to guide the entire structure, the prosthetic valve, into place at the mitral annulus during deployment and to keep the valve in place once it is deployed. Another important function is to reduce pulmonary edema by improving atrial drainage.
The valve leaflets are held by, or within, a leaflet assembly. In some embodiments, the leaflet assembly comprises a leaflet wire support structure to which the leaflets are attached and the entire leaflet assembly is housed within the frame body. In this embodiment, the assembly is constructed of wire and stabilized tissue to form a suitable platform for attaching the leaflets. In this aspect, the wire and stabilized tissue allow for the leaflet structure to be compressed when the prosthetic valve is compressed within the deployment catheter, and to spring open into the proper functional shape when the prosthetic valve is opened during deployment. In this embodiment, the leaflet assembly may optionally be attached to and housed within a separate cylindrical liner made of stabilized tissue or material, and the liner is then attached to line the interior of the frame body.
In this embodiment, the leaflet wire support structure is constructed to have a collapsible/expandable geometry. In some embodiments, the structure is a single piece of wire. The wireform is, in one embodiment, constructed from a shape memory alloy such as Nitinol®. The structure may optionally be made of a plurality of wires, including between 2 to 10 wires. Further, the geometry of the wire form is without limitation, and may optionally be a series of parabolic inverted collapsible arches to mimic the saddle-like shape of the native annulus when the leaflets are attached. Alternatively, it may optionally be constructed as collapsible concentric rings, or other similar geometric forms, each of which is able to collapse or compress, then expand back to its functional shape. In some embodiments, there may be 2, 3 or 4 arches. In another embodiment, closed circular or ellipsoid structure designs are contemplated. In another embodiment, the wire form may be an umbrella-type structure, or other similar unfold-and-lock-open designs. In some embodiments utilizes super elastic Nitinol® wire approximately 0.015″ in diameter. In this embodiment, the wire is wound around a shaping fixture in such a manner that 2-3 commissural posts are formed. The fixture containing the wrapped wire is placed in a muffle furnace at a pre-determined temperature to set the shape of the wire form and to impart its super elastic properties. Secondarily, the loose ends of the wireform are joined with a stainless steel or Nitinol® tube and crimped to form a continuous shape. In some embodiments, the commissural posts of the wireform are adjoined at their tips by a circular connecting ring, or halo, whose purpose is to minimize inward deflection of the post(s).
In some embodiments, the leaflet assembly is constructed solely of stabilized tissue or other suitable material without a separate wire support structure. The leaflet assembly in this embodiment is also disposed within the lumen of the frame and is attached to the frame to provide a sealed joint between the leaflet assembly and the inner wall of the frame. By definition, it is contemplated within the scope of the invention that any structure made from stabilized tissue and/or wire(s) related to supporting the leaflets within the frame constitute a leaflet assembly. In this embodiment, stabilized tissue or suitable material may also optionally be used as a liner for the inner wall of the frame and is considered part of the leaflet assembly.
Multiple types of tissue and biocompatible material may be used to cover the cuff, to form the valve leaflets, to form a wireless leaflet assembly, and/or to line both the inner and/or outer lateral walls of outer frame 144. As stated previously, the leaflet component may be constructed solely from stabilized tissue, without using wire, to create a leaflet assembly and valve leaflets. In this aspect, the tissue-only leaflet component may be attached to the frame with or without the use of the wire form. In some embodiments, there can be anywhere from 1, 2, 3 or 4 leaflets, or valve cusps.
The tissue may be used to cover the inside of the frame body, the outside of the frame body, and the top and/or bottom side of the cuff wire form, or any combination thereof.
In some embodiments, the tissue used herein is optionally a biological tissue and may be a chemically stabilized valve of an animal, such as a pig. In some embodiments, the biological tissue is used to make leaflets that are sewn or attached to a metal frame. This tissue is chemically stabilized pericardial tissue of an animal, such as a cow (bovine pericardium) or sheep (ovine pericardium) or pig (porcine pericardium) or horse (equine pericardium).
Preferably, the tissue is bovine pericardial tissue. Examples of suitable tissue include that used in the products Duraguard®, Peri-Guard®, and Vascu-Guard®, all products currently used in surgical procedures, and which are marketed as being harvested generally from cattle less than 30 months old.
In some embodiments, the valve leaflets may optionally be made from a synthetic material such as polyurethane or polytetrafluoroethylene. Where a thin, durable synthetic material is contemplated, e.g. for covering the flared end or cuff, synthetic polymer materials such expanded polytetrafluoroethylene or polyester may optionally be used. Other suitable materials may optionally include thermoplastic polycarbonate urethane, polyether urethane, segmented polyether urethane, silicone polyether urethane, silicone-polycarbonate urethane, and ultra-high molecular weight polyethylene. Additional biocompatible polymers may optionally include polyolefins, elastomers, polyethylene-glycols, polyethersulphones, polysulphones, polyvinylpyrrolidones, polyvinylchlorides, other fluoropolymers, silicone polyesters, siloxane polymers and/or oligomers, and/or polylactones, and block co-polymers using the same.
As shown in FIG. 1, tether 160 may be attached to valve 10. Tether 160 (which may include multiple tethers) may extend to one or more tissue anchor locations within the heart. In some embodiments, the tether(s) extends downward through the left ventricle, exiting the left ventricle at the apex of the heart to be fastened on the epicardial surface outside of the heart. Similar anchoring is contemplated herein as it regards the tricuspid, or other valve structure requiring a prosthetic. There may be from 1 to 8, or more, tethers.
In some embodiments, the tether(s) may optionally be attached to the cuff to provide additional control over position, adjustment, and compliance. In some embodiments, one or more tethers are optionally attached to the cuff, in addition to, or optionally, in place of, the tethers attached to the outer frame 144. By attaching to the cuff and/or the frame, an even higher degree of control over positioning, adjustment, and compliance is provided to the operator during deployment.
During deployment, the operator is able to adjust or customize the tethers to the correct length for a particular patient's anatomy. The tether(s) also allows the operator to tighten the cuff onto the tissue around the valvular annulus by pulling the tether(s), which creates a leak-free seal.
In some embodiments, the tether(s) is optionally anchored to other tissue location(s) depending on the particular application of valve 10. In the case of a mitral valve, or the tricuspid valve, one or more tethers are optionally anchored to one or both papillary muscles, septum, and/or ventricular wall.
In some embodiments, the ventricular end of outer frame 144, or of inner frame 100, comes to 2-5 points onto which anchoring sutures or tether are affixed. The tethers will traverse the ventricle and ultimately be anchored to the epicardial surface of the heart approximately at the level of the apex. The tethers when installed under slight tension will serve to hold the valve in place, i.e. inhibit perivalvular leakage during systole.
The tethers, in conjunction with the cuff, provide greater compliance for the valve. The tethers may be made from surgical-grade materials such as biocompatible polymer suture material. Non-limiting examples of such material include ultra high-molecular weight polyethylene (UHMWPE), 2-0 exPFTE (polytetrafluoroethylene) or 2-0 polypropylene. In one embodiment the tethers are inelastic. One or more of the tethers may optionally be elastic to provide an even further degree of compliance of the valve during the cardiac cycle. Upon being drawn to and through the apex of the heart, the tethers may be fastened by a suitable mechanism such as tying off to a pledget or similar adjustable button-type anchoring device to inhibit retraction of the tether back into the ventricle. It is also contemplated that the tethers might be bioresorbable/bioabsorbable and thereby provide temporary fixation until other types of fixation take hold such a biological fibrous adhesion between the tissues and prosthesis and/or radial compression from a reduction in the degree of heart chamber dilation.
Valve 10 may optionally be deployed with a combination of installation tethers and permanent tethers, attached to outer frame 144, and/or cuff 146, and/or inner frame 100, the installation tethers being removed after the valve is successfully deployed. It is also contemplated that combinations of inelastic and elastic tethers may optionally be used for deployment and to provide structural and positional compliance of the valve during the cardiac cycle.
Valve 10 may be deployed as a prosthetic mitral valve using catheter delivery techniques. The entire valve 10 is compressed within a narrow catheter and delivered to the annular region of the native valve, preferably the left atrium, with a pre-attached tether apparatus. There, the valve 10 is pushed out of the catheter where it springs open into its pre-formed functional shape without the need for manual expansion using an inner balloon catheter. When the valve 10 is pulled into place, the outer frame 144 is seated in the native mitral annulus, leaving the cuff 146 to engage the atrial floor and prevent pull-through (where the valve is pulled into the ventricle). The native leaflets are not cut-away as has been taught in prior prosthetic efforts, but are used to provide a tensioning and sealing function around the outer frame 144. The valve 10 is preferably deployed asymmetrically to address LVOT problems, unlike non-accommodating prosthetic valves that push against the A2 anterior segment of the mitral valve and close blood flow through the aorta, which anatomically sits immediately behind the A2 segment of the mitral annulus. Thus, D-shaped section 162 is preferably deployed immediately adjacent/contacting the A2 segment since the flattened D-shaped section 162 is structurally smaller and has a more vertical profile (closer to paralleling the longitudinal axis of the outer frame) and thereby exerts less pressure on the A2 segment. Once valve 10 is properly seated, tether 160 may be extended out through the apical region of the left ventricle and secured using an epicardial pad 154 or similar suture-locking attachment mechanism.
Valve 10 is, in one embodiment, apically delivered through the apex of the left ventricle of the heart using a catheter system. In one aspect of the apical delivery, the catheter system accesses the heart and pericardial space by intercostal delivery. In another delivery approach, the catheter system delivers valve 10 using either an antegrade or retrograde delivery approach using a flexible catheter system, and without requiring the rigid tube system commonly used. In another embodiment, the catheter system accesses the heart via a trans-septal approach.
In some embodiments, the frame body extends into the ventricle about to the edge of the open mitral valve leaflets (approximately 25% of the distance between the annulus and the ventricular apex). The open native leaflets lay against the outside frame wall and parallel to the long axis of the frame (i.e. the frame holds the native mitral valve open).
In some embodiments, the diameter should approximately match the diameter of the mitral annulus. Optionally, the valve may be positioned to sit in the mitral annulus at a slight angle directed away from the aortic valve such that it is not obstructing flow through the aortic valve. Optionally, the outflow portion (bottom) of the frame should not be too close to the lateral wall of the ventricle or papillary muscle as this position may interfere with flow through the prosthesis. As these options relate to the tricuspid, the position of the tricuspid valve may be very similar to that of the mitral valve.
In one embodiment, to control the potential tearing of tissue at the apical entry point of the delivery system, a circular, semi-circular, or multi-part pledget may be employed. The pledget may be constructed from a semi-rigid material such as PTFE felt. Prior to puncturing of the apex by the delivery system, the felt is firmly attached to the heart such that the apex is centrally located. Secondarily, the delivery system is introduced through the central area, or orifice as it may be, of the pledget. Positioned and attached in this manner, the pledget acts to control any potential tearing at the apex.
In another embodiment the valve can be seated within the valvular annulus through the use of tines or barbs. These may be used in conjunction with, or in place of one or more tethers. The tines or barbs are located to provide attachment to adjacent tissue. In some embodiments, the tines are optionally circumferentially located around the bend/transition area between frame body 144 and the cuff 146. Such tines are forced into the annular tissue by mechanical means such as using a balloon catheter. In one non-limiting embodiment, the tines may optionally be semi-circular hooks that upon expansion of the frame body, pierce, rotate into, and hold annular tissue securely.
One embodiment of an inner frame 100 is shown in side view in FIG. 2. Frame 100 includes a cylindrical framework 102 defining a lumen 104, and including three generally diamond-shaped members 106, 108, 110. Each diamond-shaped member is directly connected to, or has at least one connecting member 120 connecting to, each of the other two diamond-shaped members. Spanning members 122 cross the open span of the diamond-shaped members and provide a strengthening structural enhancement, another sewing anchor location for the other components of inner assembly 12, or both.
Another embodiment of inner frame 100 is shown in side view in FIG. 3. This embodiment includes optional valve sewing rings 105 and tether attachment structures 111. Each valve sewing ring 105 provides an aperture for sewing the leaflet tissue structures to the wire framework 100.
Another embodiment of inner frame 100 is shown in an opened and flattened view in FIG. 4. This view is intended primarily for illustrative purposes of the wireframe structure, since the manufacture of the cylindrical framework will generally be made from a laser-cut piece of Nitinol® tubing that is expanded to form a larger cylindrical structure, and the wireframe structure will generally not be manufactured from a rolled-up welded metal lattice. FIG. 4 shows each diamond-shaped member defining two lateral vertices 112 and 114 and two longitudinal vertices 116 and 118. Each diamond-shaped member is directly connected to, or has at least one connecting member 120 connecting to, each of the other two diamond-shaped members. The connecting members defined in this embodiment as joined legs 126, 128 connected at a V-shaped connecting vertex 124. FIG. 4 also shows spanning members 122 crossing the open span of the diamond-shaped members and providing a strengthening structural enhancement, another sewing anchor location, or both. FIG. 4 shows point A and point B, which are the locations at which the connecting members are joined to form a cylindrical structure (or said another way, the location at which the tubular inner frame 100 is cut to be opened up and flattened for the view shown in FIG. 4).
Another embodiment of an inner frame, in this instance designated 200, is shown in FIG. 5 in a flattened view Inner frame 200 includes a cylindrical framework 202 defining a lumen 204. As in FIG. 4, this view in FIG. 5 is intended primarily for illustrative purposes of the wireframe structure, and point A and point B designate the locations at which the wireframe is joined to form a cylindrical structure.
Another embodiment of an inner frame, in this instance designated 300, is shown in flattened view in FIG. 6. Inner frame 300 includes three diamond-shaped members, not having spanning members. Cylindrical framework 302 defines a lumen 304 using each of diamond-shaped members 306, 308, and 310. FIG. 6 again shows point A and point B, which are the locations at which the connecting members are joined to form a cylindrical structure.
Another embodiment of an inner frame, in this instance designated 400, is shown in side view in FIG. 7. This four-diamond embodiment includes a cylindrical framework 402 defining a lumen 404, in which cylindrical framework 402 includes four generally diamond-shaped members.
A flattened view of another four-diamond embodiment of inner frame 400 is shown in a flattened view in FIG. 8. FIG. 8 shows diamond-shaped members 406, 407, 408, and 409, each having joining legs, shown for 406 as joining components (legs) 426 and 428, which define vertices, such as that shown at joined end 432. FIG. 8 also shows spanning members, such as that shown at 422, crossing the open span of the diamond-shaped members and providing a strengthening structural enhancement, another sewing anchor location, or both. FIG. 8 again shows point A and point B, which are the locations at which the connecting members are joined to form a cylindrical structure.
Another embodiment of an inner frame, in this instance designated 500, is shown in flattened view in FIG. 9 Inner frame 500 includes cylindrical framework 502 defining lumen 504.
Another embodiment of an inner frame, in this instance designated 600, is shown in flattened view in FIG. 10. Inner frame 600 includes cylindrical wireframe 602 defining a lumen 604 using diamond-shaped members 606, 607, 608, and 609. Each diamond-shaped member is joined at a connecting point, such as that shown at 628.
Another embodiment of an inner frame, in this instance designated 700, is shown in side view in FIG. 11 and in flattened view in FIG. 12. This embodiment has three square-shaped members connected by a v-shaped joining element. Square-shaped members 706, 708, and 710, each have a v-shaped joining element, such as that shown as 724. Inner frame 700 also includes lateral vertices 712, 714 and longitudinal vertices 716, 718 and spanning members, such as that shown at 722, crossing the open span of the square-shaped members and providing a strengthening structural enhancement, another sewing anchor location, or both. Again, point A and point B are the locations at which the integral connecting members make their connection to form a cylindrical structure.
Another embodiment of a prosthetic valve is shown in exploded view in FIG. 13. Valve 10′ also includes an inner structure or assembly 12 and an outer structure or assembly 14. Valve 10′ may also be coupled to a tether 160 and a tether anchor 154.
Inner assembly 12 includes inner frame 302, outer cylindrical wrap 152, and leaflet structure 136 (including articulating leaflets 138 that define a valve function). As in the embodiment in FIG. 1, leaflet structure 136 may be sewn to inner frame 302, and may use parts of inner frame 302 for this purpose. Inner assembly 12 is disposed within and secured within outer assembly 14.
Outer assembly 14 includes outer frame 144. Outer frame 144 may also have in various embodiments an outer frame cover of tissue or fabric (not pictured), or may be left without an outer cover to provide exposed wireframe to facilitate in-growth. Outer frame 144 has an articulating collar or cuff 147 is covered by cover 148 of tissue or fabric. Cuff 147 may also have in some embodiments a vertical A2 section to accommodate and solve left ventricular outflow tract (LVOT) obstruction issues.
In this embodiment, tether 160 is connected to valve 10′ by outer frame 144, in contrast to the embodiment in FIG. 1, in which the tether is attached to valve 10 by inner frame 100. To implement this alternative tether attachment, in this embodiment, outer frame 144 also has attachment members or struts 113. A tether anchor 156 can be attached to the lower ends of the struts, and tether 160 can be attached to tether anchor 156. In this embodiment, tether 160 can be connected to epicardial securing pad 154.
An embodiment of an outer frame 144 having attachment members or struts 113 is shown in FIGS. 14A to 14C. In this embodiment, outer frame 144 is formed from a milled or laser-cut tube of Nitinol®. FIG. 14A shows the tube as initially milled or laser cut, i.e. before deformation. The tube can be divided into four portions, corresponding to functionally different portions of the outer frame 144 in final form: cuff portion 246, frame body portion 245, strut portion 243, and tether connecting portion 242. Strut portion 243 includes six struts 213, which connect body portion 245 to tether clamp portion 242. Connecting portion 242 includes longitudinal extensions of struts 213, connected circumferentially by pairs of opposed, slightly V-shaped connecting members (or “micro-Vs”). Connecting portion 242 is configured to be radially collapsed by application of a compressive force, which causes the micro-Vs to become more deeply V-shaped, with the vertices moving closer together longitudinally and the open ends of the V shapes moving closer together circumferentially. In one embodiment, connecting portion 242 can be configured to compressively clamp or grip one end of a tether, either clamping directly onto a tether line (e.g. braided filament line) or onto an intermediate structure, such as a polymer or metal piece that is in term firmly fixed to the tether line. In another embodiment, connecting portion 242 can be coupled to a tether by a mechanical connection (e.g. stitches, pins, etc.), an adhesive connection, or any other suitable technique. In some embodiments, but clamping and one or more other connection techniques can be used in combination.
In contrast to connecting portion 242, cuff portion 246 and body portion 245 are configured to be expanded radially. Strut portion 243 forms a longitudinal connection, and radial transition, between the expanded body portion and the compressed connecting portion 242. FIG. 14B shows outer frame 244 in a partially deformed configuration, i.e. with connecting portion 242 compressed to a slightly smaller radial dimension than the initial configuration in FIG. 14A, and with cuff portion 246 and body portion 245 expanded to a slightly larger radial dimension. FIG. 14C shows outer frame 244 in a further partially deformed (though not fully deformed to the final, deployed configuration).
Another embodiment of a prosthetic valve is shown in exploded view in FIG. 15. Valve 10″ also includes an inner structure or assembly 312 and an outer structure or assembly 314. Valve 10″ may also be coupled to a tether 360 and a tether anchor 354.
Inner assembly 312 includes inner frame 340, outer cylindrical wrap 352, and leaflet structure 336 (including articulating leaflets 338 that define a valve function). As in the embodiment in FIGS. 1 and 13, leaflet structure 336 may be sewn to inner frame 340, and may use parts of inner frame 340 for this purpose. Inner assembly 312 is disposed within and secured within outer assembly 314, as described in more detail below.
Outer assembly 314 includes outer frame 370. Outer frame 370 may also have in various embodiments an outer frame cover of tissue or fabric (not pictured), or may be left without an outer cover to provide exposed wireframe to facilitate in-growth. Outer frame 370 may also have an articulating collar or cuff 347 covered by cover 348 of tissue or fabric.
In this embodiment, tether 360 is connected to valve 10″ by inner frame 340, similar to the embodiment in FIG. 1, but employing the connecting portion and strut portion features of the outer frame 144 of the valve 10′ in FIG. 13. Thus, inner frame 340 includes tether connecting or clamping portion 344 by which inner frame 340, and by extension valve 10″, is coupled to tether 360.
Inner frame 340 is shown in more detail in FIGS. 16-18. Inner frame 340 can be formed from a milled or laser-cut tube of, for example, Nitinol®. Inner frame 340 is illustrated in FIG. 16 in an undeformed, initial state, i.e. as milled or laser-cut, but cut and unrolled into a flat sheet for ease of illustration. Inner frame 340 can be divided into four portions, corresponding to functionally different portions of the inner frame 340 in final form: apex portion 341, body portion 342, strut portion 343, and tether clamp portion 344. Strut portion 343 includes six struts, such as strut 343A, which connect body portion 342 to tether clamp portion 344.
Connecting portion 344 includes longitudinal extensions of the struts, connected circumferentially by pairs of micro-V's. Similar to connecting portion 242 of outer frame 244 in FIGS. 14A-C, connecting portion 344 is configured to be radially collapsed by application of a compressive force, which causes the micro-Vs to become more deeply V-shaped, with the vertices moving closer together longitudinally and the open ends of the V shapes moving closer together circumferentially. Thus, connecting portion 344 can clamp or grip one end of a tether, either connecting directly onto a tether line (e.g. braided filament line) or onto an intermediate structure, such as a polymer or metal piece that is in term firmly fixed to the tether line. Other techniques can be used to connect a tether to connection portion 344, as discussed above for connection portion 242 of outer frame 244.
In contrast to connecting portion 344, apex portion 341 and body portion 342 are configured to be expanded radially. Strut portion 343 forms a longitudinal connection, and radial transition, between the expanded body portion and the compressed connecting portion 344.
Body portion 342 includes six longitudinal posts, such as post 342A. The posts can be used to attach leaflet structure 336 to inner frame 340, and/or can be used to attach inner assembly 312 to outer assembly 314, such as by connecting inner frame 340 to outer frame 370. In the illustrated embodiment, the posts include openings through which connecting members (such as suture filaments and/or wires) can be passed to couple the posts to other structures.
Inner frame 340 is shown in a fully deformed, i.e. to the final, deployed configuration, in side view and bottom view in FIGS. 17 and 18, respectively.
Outer frame 370 of valve 10″ is shown in more detail in FIGS. 19-21. Outer frame 370 can be formed from a milled or laser-cut tube of, for example, Nitinol®. Outer frame 370 is illustrated in FIG. 19 in an undeformed, initial state, i.e. as milled or laser-cut, but cut and unrolled into a flat sheet for ease of illustration. Outer frame 370 can be similar to outer frame 144 described above in connection with valves 10 and 10′. Outer frame 370 can be divided into a coupling portion 371, a body portion 372, and a cuff portion 373, as shown in FIG. 19.
Coupling portion 371 includes multiple openings or apertures, such as 371A, by which outer frame 370 can be coupled to inner frame 340, as discussed in more detail below.
In this embodiment, cuff portion 373 includes an indicator 374. In this embodiment, indicator 374 is simply a broader portion of the wire frame element of cuff portion 373, i.e. Indicator 374 is more apparent on radiographic or other imaging modalities than the surrounding wire frame elements of cuff portion 373. In other embodiments, indicator 374 can be any distinguishable feature (e.g., protrusion, notch, etc.) and/or indicia (e.g., lines, markings, tic marks, etc.) that enhance the visibility of the part of cuff portion 373 on which it is formed, or to which it is attached. Indicator 374 can facilitate the implantation of the prosthetic valve by providing a reference point or landmark that the operator can use to orient and/or position the valve (or any portion of the valve) with respect to the native valve or other heart structure. For example, during implantation, an operator can identify (e.g., using echocardiography) the indicator 373 when the valve is situated in a patient's heart. The operator can therefore determine the location and/or orientation of the valve and make adjustments accordingly.
Outer frame 370 is shown in a fully deformed, i.e. to the final, deployed configuration, in side view and top view in FIGS. 20 and 21, respectively. As best seen in FIG. 21, the lower end of coupling portion 371 forms a roughly circular opening (identified by “O” in FIG. 21). The diameter of this opening preferably corresponds approximately to the diameter of body portion 342 of inner frame 340, to facilitate coupling of the two components of valve 10″.
Outer frame 370 and inner frame 340 are shown coupled together in FIGS. 22-24, in front, side, and top views, respectively. The two frames collectively form a structural support for a prosthetic valve such as valve 10″ in FIG. 15. The frames support the valve leaflet structure in the desired relationship to the native valve annulus, support the coverings for the two frames to provide a barrier to blood leakage between the atrium and ventricle, and couple to the tether (by the inner frame 340) to aid in holding the prosthetic valve in place in the native valve annulus by the tether connection to the ventricle wall. The two frames are connected at six coupling points (representative points are identified as “C”). In this embodiment, the coupling points are implemented with a mechanical fastener, such as a short length of wire, passed through aperture (such as aperture 371A) in coupling portion 371 of outer frame 370 and corresponding openings in longitudinal posts (such as poste 342A) in body portion 342 of inner frame 340. Inner frame structure 340 is thus disposed within the outer frame 370 and secured coupled to it.
US2697008 9 oct. 1953 14 déc. 1954 Globe Automatic Sprinkler Co Sprinkler head
US4003382 25 juil. 1975 18 janv. 1977 Ethicon, Inc. Retention catheter and method of manufacture
US4073438 3 sept. 1976 14 févr. 1978 Nelson Irrigation Corporation Sprinkler head
US4585705 9 nov. 1983 29 avr. 1986 Dow Corning Corporation Hard organopolysiloxane release coating
US4626255 19 sept. 1984 2 déc. 1986 Christian Weinhold Heart valve bioprothesis
US4638886 21 oct. 1985 27 janv. 1987 Sta-Rite Industries, Inc. Apparatus for disabling an obstructed lift mechanism
US4824180 8 févr. 1988 25 avr. 1989 Bendix France Brake corrector subject to the load of a vehicle
US4830117 24 déc. 1987 16 mai 1989 Fire Sprinkler Specialties, Inc. Shut-off device for an automatic sprinkler
US4923013 14 août 1989 8 mai 1990 Gennaro Sergio K De Fire sprinkler system and automatic shut-off valve therefor
US4996873 27 nov. 1989 5 mars 1991 Nissan Motor Company, Limited Washer-type pressure sensor
US5415667 4 juin 1991 16 mai 1995 Frater; Robert W. M. Mitral heart valve replacements
US5697905 19 juin 1995 16 déc. 1997 Leo T. d'Ambrosio Triple-lumen intra-aortic catheter
US6575252 29 mai 2001 10 juin 2003 Jeffrey Paul Reed Sprinkler head deactivating tool
US6648077 12 juil. 2001 18 nov. 2003 Bryan K. Hoffman Fire extinguishing system
US6726715 23 oct. 2001 27 avr. 2004 Childrens Medical Center Corporation Fiber-reinforced heart valve prosthesis
US6740105 6 nov. 2002 25 mai 2004 Mind Guard Ltd. Expandable delivery appliance particularly for delivering intravascular devices
US6854668 29 avr. 2002 15 févr. 2005 Victaulic Company Of America Extended coverage ordinary hazard sprinkler system
US6976543 23 janv. 2004 20 déc. 2005 Grinnell Corporation Low pressure, extended coverage, upright fire protection sprinkler
US7141064 8 mai 2002 28 nov. 2006 Edwards Lifesciences Corporation Compressed tissue for heart valve leaflets
US7275604 12 oct. 2005 2 oct. 2007 Wall Terry M Multi-zone firewall detection system
US7422072 6 oct. 2006 9 sept. 2008 Kent Demond Dade Sprinkler wedge
US7510572 9 oct. 2001 31 mars 2009 Shlomo Gabbay Implantation system for delivery of a heart valve prosthesis
US7632304 7 sept. 2005 15 déc. 2009 Rbkpark Llc Coronary stent
US7635386 7 mars 2007 22 déc. 2009 University Of Maryland, Baltimore Methods and devices for performing cardiac valve repair
US7674286 18 déc. 2003 9 mars 2010 Edwards Lifesciences Corporation Annular prosthesis for a mitral valve
US7695510 11 oct. 2005 13 avr. 2010 Medtronic Vascular, Inc. Annuloplasty device having shape-adjusting tension filaments
US7837727 15 août 2008 23 nov. 2010 Transcatheter Technologies Gmbh Minimally invasive heart valve replacement
US7854762 22 mai 2006 21 déc. 2010 Mayo Foundation For Medical Education And Research Devices and methods for reducing cardiac valve regurgitation
US7931630 5 juil. 2005 26 avr. 2011 C. R. Bard, Inc. Multi-functional and modular urine collection system
US7955247 27 juin 2003 7 juin 2011 The General Hospital Corporation Systems for and methods of repair of atrioventricular valve regurgitation and reversing ventricular remodeling
US7955385 28 févr. 2005 7 juin 2011 Medtronic Vascular, Inc. Device, system, and method for aiding valve annuloplasty
US8043368 23 nov. 2005 25 oct. 2011 Traves Dean Crabtree Methods and apparatus for atrioventricular valve repair
US8157810 26 févr. 2004 17 avr. 2012 Cook Medical Technologies Llc Prosthesis adapted for placement under external imaging
US8167934 26 sept. 2007 1 mai 2012 Laboratoires Perouse Implant which is intended to be placed in a blood vessel
US8206439 22 févr. 2005 26 juin 2012 International Heart Institute Of Montana Foundation Internal prosthesis for reconstruction of cardiac geometry
US8486138 19 août 2008 16 juil. 2013 Valvexchange Inc. Method and apparatus for prosthetic valve removal
US8578705 18 juil. 2007 12 nov. 2013 Ricardo Uk Limited Control of selective catalytic reduction
US8685086 1 juil. 2010 1 avr. 2014 The Cleveland Clinic Foundation Apparatus and method for replacing a diseased cardiac valve
US8900214 28 mars 2008 2 déc. 2014 Onset Medical Corporation Expandable trans-septal sheath
US20020010427 28 sept. 2001 24 janv. 2002 Symbiosis Corporation Endoscopic infusion needle having dual distal stops
US20020116054 20 févr. 2001 22 août 2002 Lundell Beverley I. Flow system for medical device evaluation and production
US20020139056 5 mars 2001 3 oct. 2002 Finnell Lee M. Fire protection system
US20030010509 12 juil. 2001 16 janv. 2003 Hoffman Bryan K. Fire extinguishing system
US20030036698 16 août 2001 20 févr. 2003 Robert Kohler Interventional diagnostic catheter and a method for using a catheter to access artificial cardiac shunts
US20040097865 12 sept. 2003 20 mai 2004 Anderson Steven C. Suture trimmer
US20040163828 21 oct. 2003 26 août 2004 Silverstein Jordan R. Fire sprinkler flow control device
US20050004652 22 avr. 2004 6 janv. 2005 Van Der Burg Eric J. Method for left atrial appendage occlusion
US20050107661 14 déc. 2004 19 mai 2005 Lilip Lau Expandable cardiac harness for treating congestive heart failure
US20050113810 16 avr. 2004 26 mai 2005 Houser Russell A. Shaping suture for treating congestive heart failure
US20050121206 11 janv. 2005 9 juin 2005 Dolan Kevin M. Sprinkler assembly
US20050125012 16 avr. 2004 9 juin 2005 Houser Russell A. Hemostatic patch for treating congestive heart failure
US20060042803 25 févr. 2005 2 mars 2006 Jeanette M. Gallaher Sprinkler head shut-off tool
US20060047338 2 sept. 2004 2 mars 2006 Scimed Life Systems, Inc. Cardiac valve, system, and method
US20060094983 15 déc. 2005 4 mai 2006 Burbank Fred H Methods and apparatus for securing medical instruments to desired locations in a patient's body
US20060161249 22 nov. 2005 20 juil. 2006 Fidel Realyvasquez Ring-shaped valve prosthesis attachment device
US20060167541 22 nov. 2005 27 juil. 2006 Lattouf Omar M Treatments for a patient with congestive heart failure
US20060229708 7 févr. 2006 12 oct. 2006 Powell Ferolyn T Methods, systems and devices for cardiac valve repair
US20060247491 27 avr. 2005 2 nov. 2006 Vidlund Robert M Devices and methods for heart valve treatment
US20060287716 7 juin 2006 21 déc. 2006 The Cleveland Clinic Foundation Artificial chordae
US20070061010 11 sept. 2006 15 mars 2007 Hauser David L Device and method for reshaping mitral valve annulus
US20070066863 31 août 2006 22 mars 2007 Medtronic Vascular, Inc. Device for treating mitral valve regurgitation
US20070078297 30 août 2006 5 avr. 2007 Medtronic Vascular, Inc. Device for Treating Mitral Valve Regurgitation
US20070083259 11 oct. 2005 12 avr. 2007 Medtronic Vascular, Inc. Annuloplasty device having shape-adjusting tension filaments
US20070118154 23 nov. 2005 24 mai 2007 Crabtree Traves D Methods and apparatus for atrioventricular valve repair
US20070118210 17 nov. 2006 24 mai 2007 Leonard Pinchuk Trileaflet Heart Valve
US20070118213 23 nov. 2005 24 mai 2007 Didier Loulmet Methods, devices, and kits for treating mitral valve prolapse
US20070185565 22 nov. 2006 9 août 2007 Ventor Technologies Ltd. Fluid flow prosthetic device
US20070215362 20 mars 2006 20 sept. 2007 Fire Sprinkler System, Inc. Fire sprinkler system
US20070221388 16 mars 2007 27 sept. 2007 Noveon, Inc. Fire Suppression System
US20070256843 4 mai 2006 8 nov. 2007 The Reliable Automatic Springkler Co., Inc. Enhanced protection extended coverage pendent fire protection sprinkler
US20070267202 29 nov. 2005 22 nov. 2007 Alain Mariller System, in Particular, Fire-Fighting System with Valves
US20070293944 29 août 2007 20 déc. 2007 Benjamin Spenser Paravalvular leak detection, sealing and prevention
US20080082163 3 oct. 2006 3 avr. 2008 St.Jude Medical, Inc. Prosthetic heart valves
US20080125861 5 févr. 2008 29 mai 2008 Webler William E Valve aptation assist device
US20080147179 19 déc. 2007 19 juin 2008 St. Jude Medical, Inc. Prosthetic heart valve including stent structure and tissue leaflets, and related methods
US20080172035 18 oct. 2006 17 juil. 2008 Starksen Niel F Methods and devices for catheter advancement and delivery of substances therethrough
US20080183203 24 janv. 2008 31 juil. 2008 Fitzgerald Timothy L Blood Vessel Occluder And Method Of Use
US20080243150 4 juin 2008 2 oct. 2008 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US20080243245 11 mars 2005 2 oct. 2008 Percutaneous Cardiovascular Solutions Pty Limited Percutaneous Heart Valve Prosthesis
US20080281411 29 mars 2005 13 nov. 2008 Eric Berreklouw Assembly Comprising A Ring For Attachment In A Passage Surrounded By Body Tissue As Well As An Applicator For Fitting The Ring In The Passage
US20080293996 6 août 2008 27 nov. 2008 Evans Michael A Systems and methods for volume reduction
US20090054974 22 oct. 2008 26 févr. 2009 Rex Medical Percutaneous aortic valve
US20090082619 2 déc. 2008 26 mars 2009 De Marchena Eduardo Method of treating cardiomyopathy
US20090088836 22 août 2008 2 avr. 2009 Direct Flow Medical, Inc. Translumenally implantable heart valve with formed in place support
US20090099410 19 mai 2006 16 avr. 2009 De Marchena Eduardo Papillary Muscle Attachment for Left Ventricular Reduction
US20090132035 12 sept. 2008 21 mai 2009 Roth Alex T Prosthetic Heart Valves, Support Structures and Systems and Methods for Implanting the Same
US20090137861 30 juil. 2008 28 mai 2009 Goldberg Roger P Apparatus and method for the treatment of stress urinary incontinence
US20090177266 5 mars 2009 9 juil. 2009 Powell Ferolyn T Methods, systems and devices for cardiac valve repair
US20090192601 23 janv. 2009 30 juil. 2009 Medtronic Vascular, Inc. Infundibular Reducer Device Delivery System and Related Methods
US20090224529 12 mars 2007 10 sept. 2009 Renishaw Plc Fluid Connector for Fluid Delivery Apparatus
US20090234318 17 oct. 2008 17 sept. 2009 Guided Delivery Systems, Inc. Systems and methods for cardiac remodeling
US20090234435 13 mars 2008 17 sept. 2009 Cardiometrix, Inc. Vascular anchoring system and method
US20100021382 12 janv. 2009 28 janv. 2010 Mallinckrodt Inc. Pyrazine Derivatives and Uses Thereof
US20100023117 15 déc. 2006 28 janv. 2010 Georgia Tech Research Corporation Papillary muscle position control devices, systems, & methods
US20100161041 4 mai 2009 24 juin 2010 Valtech Caridio, Ltd. Adjustable repair chords and spool mechanism therefor
US20100168839 4 juin 2008 1 juil. 2010 Braido Peter N Prosthetic heart valves
US20100179641 26 mars 2010 15 juil. 2010 Ryan Timothy R Multi-layered stents and methods of implanting
US20100185278 21 janv. 2010 22 juil. 2010 Tendyne Medical Apical Papillary Msucle Attachment for Left Ventricular Reduction
US20100191326 26 juin 2008 29 juil. 2010 Alkhatib Yousef F Apparatus and method for implanting collapsible/expandable prosthetic heart valves
US20100192402 23 juil. 2007 5 août 2010 Daido Sangyo Co., Ltd. Method of drying printed material and apparatus therefor
US20100210899 29 mars 2010 19 août 2010 Tendyne Medical, Inc. Method for percutaneous lateral access to the left ventricle for treatment of mitral insufficiency by papillary muscle alignment
US20100249489 27 mars 2009 30 sept. 2010 Robert Jarvik Intraventricular blood pumps anchored by expandable mounting devices
US20100280604 19 janv. 2010 4 nov. 2010 Valtech Cardio, Ltd. Over-wire rotation tool
US20100286768 8 janv. 2009 11 nov. 2010 Alkhatib Yousef F Delivery and retrieval systems for collapsible/expandable prosthetic heart valves
US20100298755 30 juil. 2010 25 nov. 2010 Mcnamara Edward Devices, systems, and methods to treat heart failure having an improved flow-control mechanism
US20110004296 10 sept. 2008 6 janv. 2011 Georg Lutter Heart Valve Stent
US20110015616 12 mai 2008 20 janv. 2011 Helmut Straubinger Handle for manipulating a catheter tip, catheter system and medical insertion system for inserting a self-expandable heart valve stent
US20110029072 3 août 2009 3 févr. 2011 Shlomo Gabbay Heart valve prosthesis and method of implantation thereof
US20110112632 14 janv. 2011 12 mai 2011 Edwards Lifesciences Corporation Method of implanting a prosthetic valve in a mitral valve with pulmonary vein anchoring
US20110137397 2 déc. 2010 9 juin 2011 Edwards Lifesciences Corporation Prosthetic valve for replacing mitral valve
US20110137408 3 déc. 2010 9 juin 2011 Bjarne Bergheim Method and System For Cardiac Valve Delivery
US20110245911 30 juil. 2010 6 oct. 2011 Medtronic, Inc. Transcatheter Valve with Torsion Spring Fixation and Related Systems and Methods
US20110251682 12 avr. 2010 13 oct. 2011 Medtronic, Inc. Transcatheter Prosthetic Heart Valve Delivery System With Funnel Recapturing Feature and Method
US20110264206 21 avr. 2011 27 oct. 2011 Medtronic, Inc. Prosthetic Valve with Sealing Members and Methods of Use Thereof
US20110288637 11 févr. 2010 24 nov. 2011 De Marchena Eduardo Percutaneous Mitral Annular Stitch to Decrease Mitral Regurgitation
US20110319988 8 déc. 2010 29 déc. 2011 Avalon Medical, Ltd. Device and System for Transcatheter Mitral Valve Replacement
US20110319989 28 avr. 2011 29 déc. 2011 Neovasc, Inc. Transcatheter mitral valve prosthesis
US20120010694 11 févr. 2009 12 janv. 2012 Tendyne Medical, Inc. Catheter
US20120016468 18 mai 2011 19 janv. 2012 Direct Flow Medical, Inc. Low crossing profile delivery catheter for cardiovascular prosthetic implant
US20120022640 24 févr. 2011 26 janv. 2012 Yossi Gross Techniques for percutaneous mitral valve replacement and sealing
US20120035703 18 oct. 2011 9 févr. 2012 Tendyne Medical, Inc. Truncated Conical Heart Valve Stent with Anchoring Threads and Methods of Use
US20120035713 18 oct. 2011 9 févr. 2012 Tendyne Medical, Inc. Truncated Cone Heart Valve Stent
US20120035722 28 janv. 2011 9 févr. 2012 Medtronic Ventor Technologies, Ltd Mitral Prosthesis and Methods for Implantation
US20120059487 24 août 2011 8 mars 2012 Cunanan Crystal M Biomaterials with enhanced properties and devices made therefrom
US20120089171 5 oct. 2011 12 avr. 2012 Boston Scientific Scimed, Inc. Biodegradable adhesive film for vascular closure
US20120101571 20 nov. 2009 26 avr. 2012 Percutaneous Cardiovascular Solutions Pty Limited Heart valve prosthesis and method
US20120101572 20 oct. 2011 26 avr. 2012 Medtronic, Inc. Mitral Bioprosthesis with Low Ventricular Profile
US20120116351 29 nov. 2011 10 mai 2012 Chomas James E Method of Operating a Microvalve Protection Device
US20120165930 16 déc. 2011 28 juin 2012 The Foundy, Llc System for mitral valve repair and replacement
US20120203336 3 févr. 2012 9 août 2012 Annest Lon Sutherland Device and method for temporary or permanent suspension of an implantable scaffolding containing an orifice for placement of a prosthetic or bio-prosthetic valve
US20120215303 * 23 févr. 2012 23 août 2012 Cardiaq Valve Technologies, Inc. Replacement heart valve and method
US20120283824 4 mai 2012 8 nov. 2012 Georg Lutter Heart Valve Stent
US20130053950 25 oct. 2012 28 févr. 2013 Edwards Lifesciences Corporation Device and method for replacing mitral valve
US20130131788 22 janv. 2013 23 mai 2013 Cardiaq Valve Technologies, Inc. Body cavity prosthesis
US20130172978 14 déc. 2012 4 juil. 2013 Tendyne Holdings Inc. Tethers for Prosthetic Mitral Valve
US20130184811 13 janv. 2012 18 juil. 2013 Tendyne Holdings, Inc. Device and Method for Replacing Mitral Valve
US20130190861 23 janv. 2012 25 juil. 2013 Tendyne Holdings, Inc. Prosthetic Valve for Replacing Mitral Valve
US20130197622 21 mai 2012 1 août 2013 Endoluminal Sciences Pty Ltd Means for Controlled Sealing of Endovascular Devices
US20130231735 28 févr. 2013 5 sept. 2013 Foundry Newco Xii, Inc. Hydraulic delivery systems for prosthetic heart valve devices and associated methods
US20130310928 23 juil. 2013 21 nov. 2013 Foundry Newco Xii, Inc. Prosthetic heart valve devices and associated systems and methods
US20130317603 19 juil. 2013 28 nov. 2013 Foundry Newco Xii, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US20130338752 14 mars 2013 19 déc. 2013 Trivascular, Inc. Endovascular delivery system with an improved radiopaque marker scheme
US20140081323 20 sept. 2012 20 mars 2014 Depuy Mitek, Llc Anti-backup suture anchor
US20140094918 2 oct. 2012 3 avr. 2014 Alphatec Spine, Inc. Stand-alone interbody fixation system
US20140163668 3 mai 2013 12 juin 2014 Nasser Rafiee Methods and systems for delivering prostheses using rail techniques
US20140194981 10 janv. 2013 10 juil. 2014 Medtronic CV Luxembourg S.a.r.l. Anti-Paravalvular Leakage Components for a Transcatheter Valve Prosthesis
US20140214159 13 août 2012 31 juil. 2014 Tendyne Holdings, Inc. Prosthetic valves and related inventions
US20140222142 7 févr. 2014 7 août 2014 Medtronic, Inc. Heart Valve Prosthesis
US20140243966 1 avr. 2014 28 août 2014 Medtronic, Inc. Anti-Paravalvular Leakage Component for a Transcatheter Valve Prosthesis
US20140277419 12 mars 2013 18 sept. 2014 Medtronic, Inc. Anti-Paravalvular Leakage Component for a Transcatheter Valve Prosthesis
US20140296969 14 janv. 2014 2 oct. 2014 Tendyne Holdlings, Inc. Anterior Leaflet Clip Device for Prosthetic Mitral Valve
US20140296970 19 mars 2014 2 oct. 2014 Tendyne Holdings, Inc. Positioning Tool for Transcatheter Valve Delivery
US20140296971 17 avr. 2014 2 oct. 2014 Tendyne Holdings Alignment Device for Asymmetric Transcatheter Valve
US20140296972 17 avr. 2014 2 oct. 2014 Tendyne Holdings Deployment Compensator for Transcatheter Valve Delivery
US20140296975 14 janv. 2014 2 oct. 2014 Tendyne Holdlings, Inc. Inflatable Annular Sealing Device for Prosthetic Mitral Valve
US20140303718 14 janv. 2014 9 oct. 2014 Tendyne Holdings, Inc. Retrieval and repositioning system for prosthetic heart valve
US20140316516 2 juil. 2014 23 oct. 2014 Tendyne Holdings, Inc. Multi-component cuff designs for transcatheter mitral valve replacement subvalvular sealing apparatus for transcatheter mitral valves and wire framed leaflet assembly
US20140324161 11 juil. 2014 30 oct. 2014 Tendyne Holdings, Inc. Retrieval and repositioning system for prosthetic heart valve
US20140324164 5 août 2012 30 oct. 2014 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
US20140358224 15 janv. 2014 4 déc. 2014 Tendyne Holdlings, Inc. Six cell inner stent device for prosthetic mitral valves
US20140364944 21 août 2014 11 déc. 2014 Georg Lutter Truncated cone heart valve stent
US20140379076 15 janv. 2014 25 déc. 2014 Tendyne Holdings, Inc. Halo Wire Fluid Seal Device for Prosthetic Mitral Valves
US20150005874 24 avr. 2014 1 janv. 2015 Tendyne Holdings, Inc. Atrial Thrombogenic Sealing Pockets for Prosthetic Mitral Valves
US20150057705 25 mars 2014 26 févr. 2015 Tendyne Holdings, Inc. Pursestring Epicardial Pad Device
US20150119978 29 oct. 2014 30 avr. 2015 Tendyne Holdings, Inc. Apparatus and methods for delivery of transcatheter prosthetic valves
US20150127096 29 déc. 2014 7 mai 2015 Edwards Lifesciences Corporation Method for replacing mitral valve
US20150142100 19 oct. 2012 21 mai 2015 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US20150142103 28 janv. 2015 21 mai 2015 Tendyne Holdings, Inc. Multi-component designs for heart valve retrieval device, sealing structures and stent assembly
US20150142104 19 nov. 2014 21 mai 2015 St. Jude Medical, Cardiology Division, Inc. Sealing structures for paravalvular leak protection
US20150173897 20 mai 2013 25 juin 2015 Tel Hashomer Medical Research Infrastructure And Services Ltd. Prosthetic mitral valve
US20150196393 14 août 2012 16 juil. 2015 Tendyme Holdings, Inc. Delivery systems and methods for transcatheter prosthetic valves
US20150202044 27 août 2014 23 juil. 2015 Mark Chau Prosthetic valve for replacing mitral valve
US20150216653 5 août 2013 6 août 2015 Pfm Medical Ag Implantable device for use in the human and/or animal body to replace an organ valve
US20150223934 11 févr. 2015 13 août 2015 Tendyne Holdings, Inc. Adjustable tether and epicardial pad system for prosthetic heart valve
US20150238729 23 févr. 2015 27 août 2015 Mark Lynn Jenson Cardiac Access Catheter, System, and Method
US20150272731 1 avr. 2014 1 oct. 2015 Medtronic, Inc. System and Method of Stepped Deployment of Prosthetic Heart Valve
US20150305860 23 avr. 2014 29 oct. 2015 Medtronic, Inc. Paravalvular Leak Resistant Prosthetic Heart Valve System
US20150305864 1 mai 2015 29 oct. 2015 Cardiaq Valve Technologies, Inc. Replacement heart valves, delivery devices and methods
US20150305868 22 juin 2015 29 oct. 2015 Georg Lutter Truncated cone heart valve stent
US20150335429 7 août 2015 26 nov. 2015 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US20150342717 1 juin 2015 3 déc. 2015 Michael J. O'Donnell Temporary valve and filter on guide catheter
US20150351903 19 oct. 2012 10 déc. 2015 Twelve, Inc. Devices, systems and methods for heart valve replacement
US20160008131 24 sept. 2015 14 janv. 2016 Tendyne Holdings, Inc. Prosthetic heart valve and systems and methods for delivering the same
US20160067042 10 sept. 2015 10 mars 2016 Edwards Lifesciences Corporation Valved aortic conduits
US20160106537 21 déc. 2015 21 avr. 2016 Tendyne Holdings, Inc Thrombus management and structural compliance features for prosthetic heart valves
US20160143736 20 janv. 2016 26 mai 2016 Tendyne Holdings, Inc. Epicardial anchor devices and methods
US20160151155 8 févr. 2016 2 juin 2016 Georg Lutter Truncated cone heart valve stent
US20160206280 30 mars 2016 21 juil. 2016 Tendyne Holdings, Inc. Apparatus and methods for alignment and deployment of intracardiac devices
USRE44075 5 juin 2008 12 mars 2013 Medtronic, Inc. Means and method of replacing a heart valve in a minimally invasive manner
CN2902226Y 9 nov. 2005 23 mai 2007 王蓉珍 人工心脏支架瓣膜
DE102006052564B3 6 nov. 2006 13 déc. 2007 Georg Lutter Mitral valve stent for surgical implantation and fixation of heart valve prosthesis to heart, has stent clips arranged distally, where one of stent clips forms section that is externally rolled in unfolded condition of stent
DE102006052710A1 8 nov. 2006 29 mai 2008 Siemens Ag Device for investigation and execution of interventions, puncture and injections in body cavities of human or animal body, has catheter with distal end and two lumens partly parallel to each other
DE102007043831A1 13 sept. 2007 2 avr. 2009 Lozonschi, Lucian, Madison Catheter has catheter body that is arranged between sections, where sections are arranged in successive manner, and hollow space that is formed with opening to penetrate catheter wall
EP2111800A1 27 juil. 1999 28 oct. 2009 Edwards Lifesciences AG Transventricular implant tools and devices
JP2003505146A Titre non disponible
JP2009514628A Titre non disponible
NL1017275A Titre non disponible
WO2000030550A1 25 oct. 1999 2 juin 2000 Quickie, Llc Passive knotless suture terminator system
WO2001035878A2 17 nov. 2000 25 mai 2001 Thermamed Gmbh Medical warming device
WO2001056512A1 1 févr. 2001 9 août 2001 Snyders Robert V Artificial heart valve
WO2001061289A1 8 févr. 2001 23 août 2001 Sartorius Ag Display and control unit for a weighing apparatus
WO2001082840A1 9 févr. 2001 8 nov. 2001 Shlomo Gabbay Method and system for providing a biologically covered heart valve prosthesis
WO2002004757A1 6 juil. 2001 17 janv. 2002 David Paul Aviram Inter-lockable structural panel sets
WO2002028321A2 26 sept. 2001 11 avr. 2002 Edwards Lifesciences Corporation Minimally-invasive annuloplasty repair segment delivery template system
WO2002049540A2 17 déc. 2001 27 juin 2002 The Cleveland Clinic Foundation Bioprosthetic cardiovascular valve system
WO2003030776A2 8 oct. 2002 17 avr. 2003 Shlomo Gabbay Heart valve prosthesis and method of its implantation
WO2003049619A2 6 déc. 2002 19 juin 2003 Lattouf Omar M Treatments for a patient with congestive heart failure
WO2006014233A2 21 juin 2005 9 févr. 2006 Xtent, Inc. Apparatus and methods for positioning prostheses for deployment from a catheter
WO2006070372A2 29 déc. 2005 6 juil. 2006 Ventor Technologies, Ltd. Fluid flow prosthetic device
WO2006113906A1 20 avr. 2006 26 oct. 2006 The Cleveland Clinic Foundation Apparatus and method for replacing a cardiac valve
WO2008125906A2 10 sept. 2007 23 oct. 2008 Anulex Technologies, Inc. Apparatus and methods for the treatment of the intervertebral disc
WO2009024859A2 21 août 2008 26 févr. 2009 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
WO2009026563A2 22 août 2008 26 févr. 2009 Direct Flow Medical, Inc. Translumenally implantable heart valve with formed in place support
WO2010090878A2 21 janv. 2010 12 août 2010 Tendyne Medical, Inc. Apical papillary muscle attachment for left ventricular reduction
WO2011017440A2 4 août 2010 10 févr. 2011 Mayo Foundation For Medical Education And Research Implanting organ ports
WO2011072084A2 8 déc. 2010 16 juin 2011 Avalon Medical Ltd. Device and system for transcatheter mitral valve replacement
WO2011106735A1 25 févr. 2011 1 sept. 2011 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for endoluminal valve creation
WO2011163275A2 21 juin 2011 29 déc. 2011 Cardiaq Valve Technologies, Inc. Replacement heart valve
WO2012177942A2 21 juin 2012 27 déc. 2012 Hanson Gifford, Iii Prosthetic heart valve devices and associated systems and methods
WO2013175468A2 20 mai 2013 28 nov. 2013 Tel Hashomer Medical Research Infrastructure And Services Ltd. Prosthetic mitral valve
WO2014121280A2 4 févr. 2014 7 août 2014 Twelve, Inc. Hydraulic delivery systems for prosthetic heart valve devices and associated methods
WO2014144937A2 14 mars 2014 18 sept. 2014 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
WO2014162306A2 18 avr. 2014 9 oct. 2014 Tendyne Holdings, Inc. Improved devices and methods for transcatheter prosthetic heart valves
WO2014189974A1 20 mai 2014 27 nov. 2014 Twelve, Inc. Implantable heart valve devices, mitral valve repair devices and associated systems and methods
8 Ashton, R. C., Jr. et al.. "Development of an Intraluminal Device for the Treatment of Aortic Regurgitation: Prototype and in Vitro Testing System," Journal of Thoracic and Cardiovascular Surgery, 1996, 112:979-983.
19 Gray, H., The Aorta, Anatomy of the Human Body, 1918, Retrieved from the Internet <http://www.bartleby.com/107/142.html>, Dec. 10, 2012, 5 pages.
21 Greenhalgh, E. S., "Design and characterization of a biomimetic prosthetic aortic heart valve," 1994. ProQuest Dissertations and Theses, Department of Fiber and Polymer Science, North Carolina State University at Raleigh, 159 pages.
23 International Search Report and Written Opinion for International Application No. PCT/US2014/040188, mailed Nov. 17, 2014, 12 pages.
24 Invitation to Pay Additional Fees and Partial International Search Report for International Application No. PCT/US2014/040188, mailed Sep. 8, 2014, 5 pages.
25 Jin, X. Y. et al., "Aortic Root Geometry and Stentless Porcine Valve Competence," Seminars in Thoracic and Cardiovascular Surgery, Oct. 1999, 11(4):145-150.
26 Knudsen, L. L. et al., "Catheter-implanted prosthetic heart valves. Transluminal catheter implantation of a new expandable artificial heart valve in the descending thoracic aorta in isolated vessels and closed chest pigs," The International Journal of Artificial Organs, 1993, 16(5):253-262.
27 Kolata, G., "Device That Opens Clogged Arteries Gets a Failing Grade in a New Study," New York Times [online], <http://www.nytimes.com/1991/01/03/health/device-that-opens-clogged-arteries-gets-a-faili . . . ,>, published Jan. 3, 1991, retrieved from the Internet on Feb. 5, 2016, 3 pages.
28 Lawrence, D. D., "Percutaneous Endovascular Graft: Experimental Evaluation," Radiology, 1987, 163:357-360.
29 Lozonschi, L., et al. "Transapical mitral valved stent implantation: A survival series in swine," The Journal of Thoracic and Cardiovascular Surgery, 140(2):422-426 (Aug. 2010) published online Mar. 12, 2010, 1 page.
30 Lutter, G. et al., "Mitral Valved Stent Implantation," European Journal of Cardio-Thoracic Surgery, 2010, 38:350-355. 2 pages.
31 Ma, L. et al., "Double-crowned valved stents for off-pump mitral valve replacement," European Journal of Cardio-Thoracic Surgery, Aug. 2005, 28(2):194-198.
32 Moazami, N. et al., "Transluminal aortic valve placement: A feasibility study with a newly designed collapsible aortic valve," ASAIO Journal, Sep./ Oct. 1996, 42(5):M381-M385.
33 Office Action for Chinese Application No. 201480037269.5, mailed Dec. 23, 2016.
34 Orton, C., "Mitralseal: Hybrid Transcatheter Mitral Valve Replacement," Retrieved from the Internet: <http:/www.acvs.org/symposium/proceedings2011/data/papers/102.pdf>, pp. 311-312.
35 Pavcnik, D. et al. "Development and Initial Experimental Evaluation of a Prosthetic Aortic Valve for Transcatheter Placement," Radiology. 1992; 183:151-154.
36 Porsimann, W. et al., "Der Verschluβ des Ductus Arteriosus Persistens ohne Thorakotomie," Thoraxchirurgie Vaskuläre Chirurgie, Band 15, Heft 2, Stuttgart, Apr. 1967, pp. 199-203.
37 Rashkind, W. J., "Creation of an Atrial Septal Defect Without Thoracotomy," The Journal of the American Medical Association, Jun. 13, 1966, 196(11):173-174.
38 Rashkind, W. J., "Historical Aspects of Interventional Cardiology: Past, Present, Future," Texas Heart Institute Journal, Dec. 1986, 13(4):363-367.
39 Reul, H. et al., "The Geometry of the Aortic Root in Health, at Valve Disease and After Valve Replacement," J. Biomechanics, 1990, 23(2):181-191.
40 Rosch, J. et al., "The Birth, Early Years and Future of Interventional Radiology," J Vasc Interv Radiol., Jul. 2003, 4:841-853.
41 Ross, D. N., "Aortic Valve Surgery," Guy's Hospital, London, 1968, pp. 192-197.
42 Rousseau, E. P. M. et al., "A mechanical analysis of the closed Hancock heart valve prosthesis," Journal of Biomechanics, 1988, 21(7):545-562.
43 Sabbah, A. N. et al., "Mechanical Factors in the Degeneration of Porcine Bioprosthetic Valves: An Overview," Dec. 1989, Journal of Cardiac Surgery, 4(4):302-309.
44 Selby, J. B., "Experience with New Retrieval Forceps for Foreign Body Removal in the Vascular, Urinary, and Biliary Systems," Radiology, 1990, 176:535-538.
45 Serruys, P. W. et al., "Stenting of Coronary Arteries. Are we the Sorcerer's Apprentice?," European Heart Journal , Sep. 1989, 10(9):774-782.
46 Sigwart, U., "An Overview of Intravascular Stents: Old and New," Chapter 48, Interventional Cardiology, 2nd Edition, W.B. Saunders Company, Philadelphia, PA, © 1994, 1990, pp. 803-815.
47 Tofeig, M. et al., "Transcatheter Closure of a Mid-Muscular Ventricular Septal Defect with an Amplatzer VSD Occluder Device," Heart, 1999, 81:438-440.
48 Uchida, B. T. et al., "Modifications of Gianturco Expandable Wire Stents," Am. J. Roentgenol., May 1988, 150(5):1185-1187.
49 US 9,155,620, 10/2015, Gross et al. (withdrawn)
50 Watt, A. H. et al., "Intravenous Adenosine in the Treatment of the Supraventricular Tachycardia; a Dose-Ranging Study and Interaction with Dipyridamole," British Journal of Clinical Pharmacology, 1986, 21:227-230.
51 Webb, J. G. et al., "Percutaneous Aortic Valve Implantation Retrograde from the Femoral Artery," Circulation, 2006, 113:842-850.
52 Wheatley, D. J., "Valve Prostheses," Rob & Smith's Operative Surgery, Fourth Edition, 1986, pp. 415-424, Butterworths.
53 Yoganathan, A. P. et al., "The Current Status of Prosthetic Heart Valves." In Polymetric Materials and Artificial Organs, American Chemical Society, 1984, pp. 111-150.
Classification internationale A61F2/24, A61L27/36, A61L27/06, A61L33/00, A61L27/14, A61L27/54, A61L27/34
Classification coopérative A61F2210/0014, A61L27/50, A61L27/06, A61F2230/0019, A61F2/2457, A61L2400/16, A61F2220/0083, A61F2250/0063, A61F2/2418, A61L27/34, A61L27/54, A61L2430/20, A61L27/14, A61L2300/236, A61F2/24, A61F2220/0041, A61F2230/0093, A61F2250/0098, A61F2/2409, A61F2220/0016, A61F2250/0039, A61L27/3629, A61F2220/0075, A61L33/0011
4 déc. 2015 AS Assignment
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:TEGELS, ZACHARY J.;EKVALL, CRAIG A.;VIDLUND, ROBERT M.;REEL/FRAME:037212/0642
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CHRISTIANSON, MARK;PERRIN, CHAD;REEL/FRAME:037212/0651